ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
Krystal Biotech Inc

Krystal Biotech Inc (KRYS)

176.39
-4.71
(-2.60%)
마감 27 2월 6:00AM
176.39
0.00
( 0.00% )
시간외 단일가: 6:59PM

행사 가격매수가매도가최근 가격중간 가격가격 변동가격 변동 %거래량미결제 약정최근 거래
125.0050.4053.900.0052.150.000.00 %00-
130.0045.4049.000.0047.200.000.00 %00-
135.0040.2044.000.0042.100.000.00 %00-
140.0035.3039.100.0037.200.000.00 %00-
145.0030.8034.500.0032.650.000.00 %00-
150.0026.1029.8036.0027.950.000.00 %00-
155.0021.5025.2033.5823.350.000.00 %00-
160.0017.4020.8028.7019.100.000.00 %0203-
165.0013.5016.7022.0515.100.000.00 %061-
170.0010.0013.4020.0011.700.000.00 %0310-
175.007.1010.1016.008.600.000.00 %01,013-
180.006.108.307.007.20-3.62-34.09 %110127/02/2025
185.002.856.9010.704.875-0.000.00 %053-
190.001.354.905.533.1250.000.00 %0543-
195.000.404.702.402.550.000.00 %02-
200.000.104.002.202.050.000.00 %022-
210.000.701.850.001.2750.000.00 %00-
220.000.202.451.501.3250.000.00 %01-
230.000.002.350.000.000.000.00 %00-

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

행사 가격매수가매도가최근 가격중간 가격가격 변동가격 변동 %거래량미결제 약정최근 거래
125.000.002.300.000.000.000.00 %00-
130.000.002.350.000.000.000.00 %00-
135.000.002.450.000.000.000.00 %00-
140.001.001.651.001.3250.000.00 %02-
145.000.201.7010.420.950.000.00 %01-
150.000.752.451.031.60-9.87-90.55 %2022127/02/2025
155.000.052.453.051.250.000.00 %05-
160.001.152.502.501.8250.000.00 %0200-
165.001.505.100.003.300.000.00 %00-
170.002.506.808.004.650.000.00 %02-
175.005.008.904.006.950.000.00 %035-
180.007.6011.606.609.601.3525.71 %1427/02/2025
185.0010.8014.6010.4512.702.3529.01 %1527/02/2025
190.0014.6018.409.0016.500.000.00 %01-
195.0018.6022.600.0020.600.000.00 %00-
200.0022.9026.600.0024.750.000.00 %00-
210.0032.0035.6030.0033.800.000.00 %1026/02/2025
220.0041.8045.800.0043.800.000.00 %00-
230.0051.2056.000.0053.600.000.00 %00-

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
TRIThomson Reuters Corporation
US$ 178.50
(791.16%)
1.22k
ULYUrgent ly Inc
US$ 0.8572
(104.10%)
17.13M
ANNAAleAnna Inc
US$ 11.31
(59.97%)
10
NIXXNixxy Inc
US$ 2.42
(53.16%)
15.27M
CPOPPop Culture Group Company Ltd
US$ 0.9682
(39.91%)
6.18M
TOIIWOncology Institute Inc
US$ 0.0186
(-54.52%)
1
UVSPUnivest Financial Corporation
US$ 21.17
(-29.34%)
6
SPGCSacks Parente Golf Inc
US$ 0.5301
(-27.59%)
365.5k
SYTASiyata Mobile Inc
US$ 3.07
(-26.38%)
91.31k
HBNCHorizon Bancorp Inc
US$ 12.30
(-25.59%)
7
ULYUrgent ly Inc
US$ 0.8562
(103.86%)
17.13M
NIXXNixxy Inc
US$ 2.41
(52.53%)
15.27M
VMARVision Marine Technologies Inc
US$ 0.99
(35.43%)
14.01M
ICCTiCoreConnect Inc
US$ 1.47
(34.86%)
12.01M
CPOPPop Culture Group Company Ltd
US$ 0.9682
(39.91%)
6.18M

KRYS Discussion

게시물 보기
Monksdream Monksdream 4 월 전
KRYS. Under $200
👍️0
Monksdream Monksdream 7 월 전
KRYS new 52 week high
👍️0
Monksdream Monksdream 10 월 전
KRYS 10Q due 5/6
👍️0
Monksdream Monksdream 11 월 전
KRYS over $30
👍️0
Monksdream Monksdream 12 월 전
KRYS new 52 week high
👍️0
Monksdream Monksdream 2 년 전
From Cathie Wood
A Novel Gene Therapy Promises Relief For A Rare Genetic Skin Disorder
ARK Invest_Illustration_Pierce Jamieson_Final_Circle 400 px By Pierce Jamieson | @PierceARK
Research Associate
Recently, the US Food and Drug Administration (FDA) approved Krysta Biotech’s (KRYS) groundbreaking advance1 in gene therapy, Vyjuvek, to treat wounds in patients suffering from dystrophic epidermolysis bullosa (DEB), a rare and serious genetic skin disorder caused by mutations in the collagen Type VII alpha 1 chain (COL7A1) gene. As the first FDA-approved gene therapy for DEB, Vyjuvek is a significant breakthrough.

Vyjuvek uses a genetically modified HSV-1 to deliver normal copies of the COL7A1 gene to wounds, restoring the integrity of the skin with fibrils that hold skin layers together. Treated with Vyjuvek, 65% of wounds closed completely.
👍️0
wiredawg wiredawg 3 년 전
Moving nicely today...
👍️0
wiredawg wiredawg 3 년 전
Looking at the few posts here there seems to be no real commitment here...any thoughts on KRYS? Hype or something brewing?
👍️0
wiredawg wiredawg 3 년 전
In the last 3 months, 5 ranked analysts set 12-month price targets for KRYS. The average price target among the analysts is $125.00. Analysts compare their price target to the current market price of the stock to determine how much potential upside or downside movement there could be in the stock price. High $140 Low $111

👍️0
wiredawg wiredawg 3 년 전
30 Nov Tues releases this PR during evening after market close:

https://ir.krystalbio.com/news-releases/news-release-details/krystal-biotech-announces-pricing-200-million-public-offering
👍️0
wiredawg wiredawg 3 년 전
29 Nov Mon after market closes release this PR:

https://ir.krystalbio.com/news-releases/news-release-details/krystal-biotech-announces-proposed-200-million-public-offering
👍️0
wiredawg wiredawg 3 년 전
29 Nov Monday pre-market news release, great move pre-market approx 7am and so far holding fairly well:

https://ir.krystalbio.com/news-releases/news-release-details/krystal-biotech-announces-positive-topline-results-gem-3-pivotal
👍️0
wiredawg wiredawg 3 년 전
This caught my eye on Monday, the huge move off the PR...I'm guessing here saw the same. Any real thoughts regarding the company and this PR. I have not gotten a chance to dig into it. Hoping to have somm DD done over the weekend.
👍️0
wiredawg wiredawg 3 년 전
Holding well so far, why the pretty hard drop?
👍️0
wiredawg wiredawg 3 년 전
Why are you surprised? Serious question, not being impudent...
👍️0
rynlrt rynlrt 3 년 전
200 million dollar offering. Won't be surprised to see it drop pretty hard when the market opens
👍️0
Fofo812 Fofo812 3 년 전
Surprised it held up this long
👍️0
crudeoil24 crudeoil24 3 년 전
Large tutes holdings. Some taking huge gains before years end.
👍️0
rynlrt rynlrt 3 년 전
Not sure this kind of gain is sustainable. May see a big pullback
👍️0
Fofo812 Fofo812 3 년 전
3rd post
👍️0
crudeoil24 crudeoil24 3 년 전
Krystal Biotech shares are trading higher after the company announced its GEM-3 trial met its primary endpoint.
👍️0
Trophy Trophy 5 년 전
..
👍️0

최근 히스토리

Delayed Upgrade Clock